CMS Administrator Dr. Mehmet Oz is championing GLP-1 weight-loss medications, like Ozempic, as a crucial tool to combat the surge in chronic diseases driven by obesity, stating they can effectively ‘jumpstart’ healthier habits for individuals struggling with weight management. Oz highlighted that these drugs, now more accessible through initiatives like the Medicare GLP-1 Bridge program offering them for $50 a month, can lead to significant cost savings for taxpayers by reducing the incidence of conditions such as high blood pressure and diabetes, which account for a substantial portion of healthcare spending. While emphasizing that GLP-1s are not a ‘silver bullet’ and must be combined with diet, exercise, and other lifestyle factors, Oz stressed their value in making it easier for people to adopt healthier lifestyles, particularly those with physical limitations or metabolic challenges.
Adapted from: Latest & Breaking News on Fox News
